Jazz Pharmaceuticals

Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Investors Business Daily
Sat, 09/21/19 - 12:28 pm
Wave Life Sciences
suvodirsen
DMD
Merck
Keytruda
Biogen
Spinraza
Zoetis
Europe
animal health
Jazz Pharmaceuticals
JZP-258
narcolepsy
Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling
Fierce Pharma
Mon, 06/17/19 - 11:22 pm
Jazz Pharmaceuticals
FDA
Sunosi
DEA
narcolepsy
A delicate balancing act for Immunogen
EP Vantage
Tue, 05/21/19 - 09:33 am
Immunogen
mirvetuximab soravtansin
Jazz Pharmaceuticals
IMGN779
IMGN632
Jazz Pharmaceuticals Hits All the Right Notes in Q1
Motley Fool
Wed, 05/8/19 - 10:13 am
Jazz Pharmaceuticals
earnings
Jazz's narcolepsy treatment passes Phase 3 test
Biopharma Dive
Wed, 03/27/19 - 11:39 am
Jazz Pharmaceuticals
narcolepsy
JZP-258
Xyrem
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
Jazz’s Vyxeos rollout hit a wall in Q3. What’s the holdup?
Fierce Pharma
Wed, 11/7/18 - 10:39 pm
Jazz Pharmaceuticals
Vyxeos
Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches
Fierce Pharma
Mon, 08/20/18 - 11:46 am
Jazz Pharmaceuticals
hirings
drug reps
solriamfetol
narcolepsy
Europe
Vyxeos
AML
U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
Reuters
Sat, 07/14/18 - 01:31 pm
Jazz Pharmaceuticals
narcolepsy
Xyrem
Amneal
generics
Kickback Allegation Settlements Pile Up for Pharmaceutical Companies
RAPS.org
Sat, 05/26/18 - 09:19 am
kickbacks
Medicare
physicians
Pfizer
Jazz Pharmaceuticals
Valeant Pharmaceuticals
Shire
Omnicare
Sparks sells regulatory fast pass to Jazz for $110M
Biopharma Dive
Mon, 04/30/18 - 09:02 pm
Spark Therapeutics
Jazz Pharmaceuticals
priority review vouchers
Jazz, ImmunoGen partner on hematology, oncology drug development
BioPharma Dive
Wed, 08/30/17 - 11:46 pm
Jazz Pharmaceuticals
Immunogen
oncology
hematology
drug development
FDA approves Jazz Pharmaceuticals’ liposomal AML chemotherapy
Drug Delivery Business News
Tue, 08/8/17 - 10:05 am
FDA
Jazz Pharmaceuticals
liposomal chemotherapy
Vyxeos
AML
Jazz nabs early FDA nod for AML med Vyxeos. Is diversifying M&A next?
Fierce Pharma
Thu, 08/3/17 - 09:49 pm
Jazz Pharmaceuticals
FDA
AML
Vyxeos
M&A
Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul
Bloomberg
Fri, 07/7/17 - 10:31 am
rare disease
healthcare reform
Shire
Jazz Pharmaceuticals
Sanofi
Roche
Biogen
Alexion
Vertex Pharmaceuticals
Upstart women’s oncology company in-licenses PhII PARP; Beijing biotech grabs $29M startup round
Endpoints
Fri, 07/7/17 - 10:18 am
oncology
PARP inhibitors
2X Oncology
Eisai
2X-121
Jazz Pharmaceuticals
3 Reasons Jazz Pharmaceuticals Stock Could Fall
Motley Fool
Sun, 06/18/17 - 11:38 pm
Jazz Pharmaceuticals
Vyxeos
Xyrem
Jazz hits a nigh note with positive narcolepsy results
BioPharma Dive
Sat, 04/29/17 - 10:03 am
Jazz Pharmaceuticals
narcolepsy
JZP-110
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Marketwatch
Thu, 04/6/17 - 09:36 am
Jazz Pharmaceuticals
Hikma
generics
Xyrem
narcolepsy
Jazz beats 4Q profit forecasts
Yahoo/AP
Wed, 03/1/17 - 09:59 am
earnings
Jazz Pharmaceuticals

Pages